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Background
Neurodegenerative diseases are a wide and complex
group of disorders, age – associated, chronic and pro-
gressive whith unknown, and probably different, aetiolo-
gies. The complexity of the phenotype is probably due
to the expression of a selective vulnerability of the dif-
ferent neuronal population and to the different patho-
genetic mechanisms. This aetiopathogenetic complexity
has been approached through the study of simple mod-
els constituted by the large Calabrian families in which
Alzheimer’s disease (AD) segregates associated to the
Presenilin 1 (PS1) Met 146Leu mutation [1] and Fronto-
temporal dementia (FTD) is caused by the Progranulin
(GRN) c1145insA mutation [2].
To investigate the phenotypic variability at onset in
patients belonging to the two families for which all data
(demographic, clinical and genetic) were available.
Materials and methods
The clinical presentations were studied in 50 out of 148
familial AD (FAD) patients (age at onset = 4 0.0±4.8;
38% women, 18 alive) and in 9 out of 34 patients (age at
onset 65.1±17.1) belonging to the FTD family.
Results
Phenotypic variability at onset in AD is broad: four
different clinical presentations may be recognized: 1)
Amnestic (38%); 2) Disoriented (20%); 3) Dysexecutive
(14%); 4) Apathetic (28 %). In the FTD, 89% of patients
presented at onset with a memory deficit and 33% were
spatially disoriented.
Conclusions
The study conducted on AD and FTD genetic models
provides evidence that different genotypes present with a
clinical overlapping at onset: symptoms classically asso-
ciated with FTD are also present in AD and, conversely,
FTD patients who are carriers of a PGRN mutation
always show a memory deficit. Knowledge advancement
calls for a steady upgrade and revision of the clinical
criteria routinely used in the diagnostic processing.
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